Atlas Trials

Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer

Clinical trial NCT02474173 · TERMINATED

Trial details

NCT number
NCT02474173
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Breast CarcinomaMetastatic Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7Triple-Negative Breast Carcinoma
Start date
2016-01-15
Primary completion
2022-10-26
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.